RegulatorWatch.com covers the issues, controversies and impacts arising from the regulation of economic, social and environmental activity in Canada/USA.
Adults are still dying from smoking-related illnesses, and some administrations aren't seeing reason. We can't back down or stop trying to make them aware of the damage they're doing. Change is needed.
#PublicHealth#Advocacy
The debate around vape flavors misses the point. As adults, we choose what to consume. If alcohol comes in countless flavors, why shouldn't vaping? Flavors help adults like me stay away from smoking.
#Vaping#AdultChoice
FDA's new draft guidance on flavored vapes creates more questions than answers. While aiming for clarity, it doesn't open the door for flavored products, especially those appealing to youth.
#FDA#Vaping#Regulations
Slowly, but surely the wheel turns. Can this be a little sunshine? Time will tell.
In the meantime, I am enforced by law to turn away grandparents and parents who are trying to remain smoke free. Some are returning to cigarettes.
The FDA seems to be acting as a tobacco control agency, not a health regulator. It's disheartening when science is ignored, especially from an administration that promised to help.
#FDA#TobaccoControl#Regulation
While FDA & Centre for Tobacco Products are beginning to acknowledge Americans badly misunderstand the relative risks of nicotine vaping products compared with cigarettes, recent research out of UT Southwestern Medical Center identifies FDA’s own Real Cost campaign “An Epidemic Is Spreading” as a significant contributor to that collapse in public understanding.
mailchi.mp/12d92930d10a/1wu9…
Legislation is often shaped by industry groups. When faced with opposition, finding common ground and negotiation can lead to model laws, even with former adversaries.
#Legislation#Advocacy#Arizona
Political rhetoric supporting vaping often clashes with tough regulatory reality, especially for flavored products. The lawful market hasn't become easier to navigate.
#VapingIndustry#Regulation
FDA's comparative efficacy standard for flavored vapes: Show your flavors are better for adult smokers quitting than tobacco flavors, or kids might be using them too much. It's a rigid rule, not a case-by-case review.
#VapeRegulation#FDA#TobaccoControl
Navigating complex regulations (federal, state, municipal) is tough. Our team of tax specialists and attorneys ensures compliance, a challenge many face. We're proud to have helped over 2 million Americans transition from smoking to vaping.
#Compliance#Regulation#PublicHealth
The science behind tobacco harm reduction is often dismissed not on its merits, but on its funding source. The tobacco industry's own studies face scrutiny, yet independent vape industry advocates are unfairly labeled.
#TobaccoHarmReduction#Vaping
Regulatory uncertainty and a high authorization bar have stifled flavored ENDS products. Despite millions spent on compliance, few flavors pass FDA review.
#FDA#Regulatory
Nicotine analogs aren't chemically nicotine, potentially placing them outside tobacco product definitions and the PMTA process. Some states, like California, are closing this loophole by including analogs in their definitions.
#VapingIndustry#Regulation#PMTA
Raising the age for tobacco and vape products to 21 effectively removes a major access point for high schoolers. By eliminating 'straw buyers' and enforcing store compliance, we're seeing a significant reduction in youth use.
#YouthPrevention#PublicHealth